A New Era in Regenerative Medicine

CollPlant is a regenerative and aesthetic medicine company developing innovative technologies and products for tissue regeneration and organ manufacturing.

Learn more



Our mission is to deliver ground-breaking products for regenerative medicine that offer the optimal treatment options for patients.

Patent families
filed
11
Peer-reviewed publications
12
Clinical experience (patients)
2000
Regenerative medicine consortiums
2

Collplant

rhCollagen production

rhCollagen: The Ideal Building Block for Regenerative Medicine

Our products are based on our revolutionary plant-based technology that enables production of recombinant human type I collagen (rhCollagen), which is identical to the collagen produced by the human body.

Learn more

3D bioprinting of trachea using CollPlant’s BioInk.
Courtesy of United Therapeutics

3D Bioprinting: Organ & Tissue Manufacturing

The advent of 3D bioprinting is expected to enable unlimited supply of tissues and organs. rhCollagen-based BioInks are ideal for 3D bioprinting. Leveraging on the unique properties of our BioInks and biomaterial know-how, we are developing a pipeline of products aimed at 3D bioprinting of tissues and organs and medical aesthetics.

Learn more

The Pipeline: Medical Aesthetics

CollPlant’s rhCollagen offers numerous opportunities in medical aesthetics, such as regenerative dermal fillers and breast implants. CollPlant's regenerative aesthetics products are currently under development.

Learn more



Our Partners


News

Contact

explore

CollPlant Biotechnologies Ltd.

4  Oppenheimer Street
P.O. Box 4132
Rehovot 7670104, Israel

local_phone +972 73 2325600
local_printshop +972 73 2325602
® 2020 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20